News

In a new study, researchers found that the inflammation behind painful episodes in sickle cell disease are correlated with ...
Hydroxyurea Significantly Reduces Infections in Children With Sickle Cell Anemia Jan. 29, 2024 — Researchers have revealed that hydroxyurea significantly reduces infections in children with ...
While de-extinction projects capture headlines with dreams of resurrecting mammoths, the same technologies at play — especially CRISPR — are quietly transforming something even more profound: human ...
Work likely to be halted by the cuts includes the collection of data for studying Americans with sickle cell, a painful blood disorder that predominantly affects Black families, as well as ...
Pfizer is voluntarily withdrawing its sickle cell disease (SCD) therapy Oxbryta from all world markets after finding an "imbalance" in deaths in its clinical trials programme. It's a blow to the ...
For adults with sickle cell disease (SCD), C-reactive protein (CRP) levels increase significantly during the follicu ...
Apr. 11, 2025 — A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments.
A PILOT study, presented at EBMT 2025 Annual Meeting, on adoptive cell therapy using memory T lymphocytes from convalescent donors shows promising results in treating severe infections in ...